Boston Scientific Investments increased by 2.7% to $643.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.9%, from $532.00M to $643.00M. Over 4 years (FY 2020 to FY 2024), Investments shows a downward trend with a -11.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in this metric generally indicates successful capital accumulation and reinvestment of earnings.
This is the aggregate value of all long-term investment assets held by the company, serving as the primary engine for ge...
A core metric for comparing the scale of investment operations across insurers.
non_current_assets_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $616.00M | $434.00M | $412.00M | $406.00M | $384.00M | $389.00M | $407.00M | $385.00M | $422.00M | $427.00M | $413.00M | $429.00M | $450.00M | $532.00M | $555.00M | $655.00M | $626.00M | $643.00M |
| QoQ Change | — | -29.5% | -5.1% | -1.5% | -5.4% | +1.3% | +4.6% | -5.4% | +9.6% | +1.2% | -3.3% | +3.9% | +4.9% | +18.2% | +4.3% | +18.0% | -4.4% | +2.7% |
| YoY Change | — | — | — | — | -37.7% | -10.4% | -1.2% | -5.2% | +9.9% | +9.8% | +1.5% | +11.4% | +6.6% | +24.6% | +34.4% | +52.7% | +39.1% | +20.9% |